| Literature DB >> 35807504 |
Madalina Nistor1, Roxana Pop1, Adela Daescu1, Adela Pintea2, Carmen Socaciu1, Dumitrita Rugina2.
Abstract
Anthocyanins are water-soluble pigments present in fruits and vegetables, which render them an extensive range of colors. They have a wide distribution in the human diet, are innocuous, and, based on numerous studies, have supposed preventive and therapeutical benefits against chronic affections such as inflammatory, neurological, cardiovascular, digestive disorders, diabetes, and cancer, mostly due to their antioxidant action. Despite their great potential as pharmaceutical applications, they have a rather limited use because of their rather low stability to environmental variations. Their absorption was noticed to occur best in the stomach and small intestine, but the pH fluctuation of the digestive system impacts their rapid degradation. Urine excretion and tissue distribution also occur at low rates. The aim of this review is to highlight the chemical characteristics of anthocyanins and emphasize their weaknesses regarding bioavailability. It also targets to deliver an update on the recent advances in the involvement of anthocyanins in different pathologies with a focus on in vivo, in vitro, animal, and human clinical trials.Entities:
Keywords: absorption; anthocyanins; bioavailability; cancer; cardiovascular diseases; diabetes; inflammatory disorders; neuropathologies; oxidative stress
Mesh:
Substances:
Year: 2022 PMID: 35807504 PMCID: PMC9268666 DOI: 10.3390/molecules27134254
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Chemical structures of the most common anthocyanidins and their color range in the visible spectrum.
Figure 2The biosynthesis pathway of ANs in plant cells. CHS: chalcone synthase, CHI: chalcone isomerase, F3H: flavanone 3-hydroxylase, F3′H: flavonoid 3′-hydroxylase, F3′5′H: flavonoid 3′,5′-hydroxylase, DFR: dihydroflavonol 4-reductase, ANS: anthocyanidin synthase, UFGT: flavonoid 3-O-glucosyltransferase, MT: O-methyl transferase (original contribution).
Figure 3Illustration of the transportation routes of ANs post-biosynthesis, from the endoplasmic reticulum (ER) to the vacuoles. ANs travel from their synthesis location to the vacuole, for storage. The first two ways, micro- (1a) and macro-autophagy (1b), involve ER-derived vesicles, which facilitate the transit of anthocyanins to the tonoplast where they attach to the membrane through soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNARE) and release the ANs inside. The other transportation method is membrane transporter-mediated pathway (2) which involves several membrane proteins (MATE, ABC, and BTL-like transporters) that facilitate the transportation of ANs inside the vacuoles and their sequestration in vacuolar inclusions (AVIs). In this case, ANs are not transported in vesicles but are conjugated by GSTs (glutathione S-transferases) and form together the GSH (glutathione)—ANs conjugate, a stable and efficient form of transportation from ER to the tonoplast (original contribution).
Figure 4Chemical and color modifications of ANs in different pH value environments. The most representative and common form of ANs, the red-colored flavylium cation, is present at acidic pH.
Figure 5Proposed scheme for the metabolism, distribution, absorption, and excretion of ANs. Copyrights Fernandes et al. [99].
In vitro studies of ANs showing their involvement in different pathologies such as diabetes, obesity, cancer, neurological, and cardiovascular.
| Cell Line | Source of ANs | Major ANs/ | Effects | References | |
|---|---|---|---|---|---|
| Diabetes and obesity | RAW264.7 (murine macrophages); 3T3-L1 (human preadipocyte) | Blackberry/ | Cy-3-glucoside | ↓NF-ƙB | [ |
| HepG2 (human hepatocellular carcinoma) | Blueberry extract | Mv | ↓ROS | [ | |
| D-HAEC (diabetic human aortic endothelial cells) | Bilberry/blueberry ANs | Cy, Dp, Pt, | ↓NF-ƙB pathway | [ | |
| Cardiovascular diseases | HUVECs (human umbilical vein endothelial cells) | Standard solutions | Cy, Pn, Dp, | ↓inflammatory and oxidative process | [ |
| Red Chinese cabbage | Cy | ↓TNF-α-induced NF-κB activity | [ | ||
| Blueberry juice | Protocatechuic acid | ↑antioxidant response of Nrf2-regulated heme oxygenase 1 (HO-1) and glutamate-cysteine ligase modifier subunit (GCLM) | [ | ||
| Standard solutions | Cy-3-glucoside | ↓levels of VCAM-1, ICAM-1, MMP-1, MMP-9 | [ | ||
| J774A.1 (murine monocyte macrophage) | Dp, Cy | ↓oxLDL | [ | ||
| Cancer | SMMC-7721 (human hepatoma cells) | Cy, Pn | ↓cell proliferation | [ | |
| HepG2 (human hepatocyte carcinoma) | Grape seeds | Pro-ANs | ✓activation of caspase-3 | [ | |
| DLD-1 | Standard solution | Dp | ↓tumor cells adhesion, migration, invasion, epithelial-to-mesenchymal transition | [ | |
| HCT-29 | Standard solutions | Dp-3-glucoside | ↓PD-1, PD-L1 | [ | |
| Colon cancer stem cells | Purple fleshed potato extract | Pt, Mv, | ↓cell proliferation | [ | |
| B16-F10 (murine melanoma cells) | Strawberry fruits | Cy, Pg, | ↑cell differentiation | [ | |
| B16-F1 (murine melanoma cells) | Mulberry fruits | Cy, Pg | ↓PI3K expression | [ | |
| MCF-7 | Black rice | Cy-3-glucoside | ↓cell viability | [ | |
| MCF-7 (human breast cancer cells) | Red sorghum bran | - | ↑apoptosis | [ | |
| HeLa (human cervical tumor Cells) | Chokeberry | Cy-3-galactoside | ✓antioxidant activity | [ | |
| MDA-MB-231 and MCF7 (human breast cancer cells) | Blueberry | Dp-3-glucoside | ↓cell invasion capacity | [ | |
| N202/1A, N202/1E (murine melanoma) | Strawberry | Pg-3-glucose | ↓cell viability | [ | |
| B16-F10 (murine melanoma cells) | Elderberries | Cy-3-sambubioside-5-glucoside | ↓cell proliferation | [ | |
| Caco-2, HT-29 (colon cancer); MDA-MB-231 (breast cancer) | Table grapes with entacapone | Cy-3-glucoside | ↓cell proliferation | [ | |
| MDA-MB-453 (breast cancer) | Black rice | Cy-3-glucoside | ↓cell migration, adhesion, motility, invasion | [ | |
| MCF-7 (breast); SF-268 (CNS); NCI-H460 (lung); HCT-116 (colon); AGS (gastric) human tumor cells | Black/Red raspberry, Blackberry | Cy-3-glucoside | ↓cell proliferation | [ | |
| B16-F10 (murine melanoma) | Blueberry | Mv-3-galactoside | ✓antioxidant activity | [ | |
| Neurological | SK-N-SH (human neuroblastoma) treated with Aβ25-35 (neurotoxic) | Standard solution | Cy-3-glucoside | ↓ROS accumulation | [ |
| SH-SY5Y (human neuroblastoma) treated with hydrogen peroxide (neurotoxic) | Blueberry/cranberry juices | Cy, Dp, | ↑SOD and CAT activity | [ |
In vivo studies of ANs and their health improvements in different pathologies such as diabetes, obesity, cancer, neurological, and cariological defects.
| Medical | Source of ANs | Target Group | Treatment | Dose of | Effect | Reference | |
|---|---|---|---|---|---|---|---|
| Diabetes and Obesity | Metabolic syndrome | Fresh bilberries | 15 volunteers | 8 weeks | 400 g | ↓IL-6, IL-12 | [ |
| Overweight/obesity | Black soybean extract | 63 obese volunteers | 8 weeks | 2.5 g/day | ↓LDLc | [ | |
| Weight control over time | Blueberries | 124,086 volunteers | 24 years | - | ✓0.07–0.10 kg less weight gained every 4 years | [ | |
| Overweight/obesity | Commercial red orange juice | 11 women | 12 weeks | 500 mL/day | ↓LDL | [ | |
| Obesity | Raspberry extract | Male C57BL/6 mice | 4 weeks | 200 mg/kg | ↓TNFα, IL-6, NF-κB gene expression | [ | |
| Obesity | Black rice | C57BL/6 mice | 12 weeks | 200 mg/kg | ↓TNFα, IL-6, iNOS, NF-κB gene expression | [ | |
| Obesity | Cherry | C57BL/6 mice | 8 weeks | 200 mg/kg | ↓29.6 and 32.7% less body weight | [ | |
| Metabolic syndrome | Wild | Obese Zucker rats | 8 weeks | 8% of diet | ↓IL-6, TNF-α, Nf-κB | [ | |
| Diabetes | Cy-3-glucoside | KK-A(y) mice | 5 weeks | 0.2% of diet | ↓RBP4 expression | [ | |
| Pre-diabetes | Kamchatka honeysuckle extract | 24 Wistar rats | 4 weeks | 327 mg ANs/g | ↑gut α and β glucosidase activity | [ | |
| Diabetic nephropathy | Purple corn extract | C57BLKS/J-Leprdb mice | 8 weeks | 10 mg/kg BW | ↓VEGF, HIF-1a | [ | |
| Pre-diabetes | Black currant extract | Sprague- | - | 5 mg/kg BW | ↑GLP-1 | [ | |
| Cardiovascular diseases/Obesity | Myocardial infarction (MI) | ANs-rich fruits and vegetables | 93,600 women, ages 25–42 | 18 years | - | ↓MI risk | [ |
| Vascular impairments | Blueberry fruits | 21 healthy men | 1, 2, 4, 6 h after ingestion | 319, 637, 766, 1278, and 1791 mg total | ↑vascular function | [ | |
| Cardiovascular risk | Strawberries | Healthy volunteers | 1 month | 500 g fruits/day | ↓cholesterol | [ | |
| Hypercholesterolemia | ANs mixture | 150 volunteers | 24 weeks | 320 mg/day | ↓hsCRP | [ | |
| Cancer | Chronic B cell lymphocytic | Bilberry extract | 30 patients | 24 h | - | ✓activation of caspase-3 | [ |
| Induced melanoma | Dp pure solution | C57BL/6N mice | 30 days | 10 mg delphinidin/kg | ↓melanoma-induced tumor growth | [ | |
| UVB-mediated apoptosis | Dp | Female SKH-1 mice | 1 and 8 h | 1 mg/0.1 DMSO/mouse | ↓apoptosis | [ | |
| UVB-induced inflammation | Cy-3-glucoside | Female SKH-1 mice | 24 h | 250 and 500 µM | ↓COX-2, iNOS, PGE2, NF-κB | [ | |
| Neuroprotection | Dementia | Cherry juice | 49 older adults (+70 years) | 12 weeks | 200 mL/day | ↑cognition | [ |
| Cognitive degradation | Freeze-dried blueberries | 37 older adults (60–75 years) | 90 days | 24 g/day | ↓verbal errors | [ | |
| Cognition improvement | Freeze-dried wild blueberries | 21 children (7–10 years) | 1, 3, 6 h | 15 or 30 g/day | ↑cognitive performance | [ | |
| Neuroinflammation mediated cognitive impairment | Korean black soybean | Male Sprague-Dawley rats | 7 weeks | 100 mg/kg ANs | ✓memory improved | [ | |
| Neuroinflammation | Korean black soybean | Male C57BL/6N mice | 14 days | 24 mg/kg/day | ↓p-NF-κB, TNF-α, and IL-1β | [ | |
| Alzheimer dementia | ANs | Male Wistar rats | - | 200 mg/kg/day | ↑SOD, CAT, GPX | [ | |
| Age-related brain deficiency | Chokeberry extract | Male Kunming mice | 8 weeks | 15 or 30 mg/kg | ↓COX2, TGF-β1 and IL-1 | [ |